Abstract
Wilson’s disease (hepatolenticular degeneration) was first characterized by S. A. Kinnear Wilson in 1912 (Wilson, 1912). It is an inherited, progressive, and, if untreated, ultimately fatal disease of copper accumulation in the human body, particularly in the liver, brain, and kidney (see Table 9-1). Indeed, the demonstration of excess copper in the liver is a requisite for the diagnosis of Wilson’s disease. The disease is usually seen as hepatic dysfunction in early adolescence, although it has been found in patients as young as four years. Symptoms are nonspecific, commonly with degenerative changes in the brain and cirrhosis of the liver. The incidence of the disease is high among Arabs, Japanese, Chinese, Indians, and Jews (Beam, 1960). The gene for Wilson’s disease appears to be located on chromosome 13 (Frydman et al., 1985).
Chapter 9 contributed by Dr. Christina A. Goode, Department of Chemistry and Biochemistry, California State University, Fullerton, California 92634.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Linder, M.C. (1991). Copper and Disease. In: Biochemistry of Copper. Biochemistry of the Elements, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9432-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9432-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9434-2
Online ISBN: 978-1-4757-9432-8
eBook Packages: Springer Book Archive